GERMANY - High Tech Beteiligungen exits Orpegen Pharma

Prior to this transaction, Berlin based Glycotope GmbH acquired the biopharmaceutical and diagnostic business unit of Orpegen for an undisclosed purchase price which was used to redeem outstanding shareholder loans. Heidelberg-based Orpegen Pharma GmbH was founded in 1982 and its business units biopharmaceuticals, diagnostics and peptide synthesis together generated a turnover of EUR 4m in 2007.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Exits
• DACH